Status:
COMPLETED
A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy
Lead Sponsor:
Teva Neuroscience, Inc.
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
This study has patients responding to two sets of surveys that will tell their doctor or nurse about their readiness to begin self-injection. In addition, patients will have their self-injection obser...
Eligibility Criteria
Inclusion
- Male or Female, 18 years of age or older, with diagnosis of RRMS
- Naive to treatment or previously treated with an IFN.
Exclusion
- Not eligible for treatment based on clinical criteria and current indication.
- Unable to respond to surveys or provide informed consent.
Key Trial Info
Start Date :
May 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
257 Patients enrolled
Trial Details
Trial ID
NCT00238654
Start Date
May 1 2003
End Date
July 1 2008
Last Update
April 12 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.